New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
June 24, 2014
10:39 EDTTV, ENR, BVN, VRTX, MEOH, OHRP, WAG, CVC, CPHigh option volume stocks
High option volume stocks: TV ENR BVN VRTX MEOH OHRP WAG ASHR CVC CP
News For TV;ENR;BVN;VRTX;MEOH;OHRP;WAG;CVC;CP From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
1 | 2 | all recent news | >>
October 13, 2014
10:53 EDTCPRailroads advance after report of Canadian Pacific approach to CSX
Subscribe for More Information
10:31 EDTCPCredit Suisse questions WSJ article on Canadian Pacific and CSX merger
Credit Suisse said it wouldn't be surprised if Canadian Pacific (CP) approached CSX (CSX), but questions its validity unless Canadian Pacific makes an official response. The analyst notes the STB rules concerning Class I mergers have an impossible hurdle rate, making a deal a non-starter.
10:08 EDTVRTXOn The Fly: Analyst Upgrade Summary
Subscribe for More Information
09:23 EDTVRTXVertex price target raised to $131 from $119 at RW Baird
Subscribe for More Information
09:21 EDTCPOn The Fly: Pre-market Movers
Subscribe for More Information
08:24 EDTCPCSX price target raised to $37 from $32 at Bernstein
Bernstein raised its price target on CSX (CSX) after The Wall Street Journal reported that the company was approached by Canadian Pacific (CP) about a possible merger. The firm thinks the deal could enable CSX to more quickly raise its margins and presents it with an opportunity to unlock significant near-term value. Bernstein says the report makes it more constructive on CSX, but it keeps a Market Perform rating on the shares.
08:01 EDTCPCanadian Pacific, CSX merger timing not ideal, says Cowen
Subscribe for More Information
07:23 EDTCPCSX volatility up, approached by Canadian Pacific on possible merger, report
Subscribe for More Information
06:41 EDTWAGWalgreens to roll out Apple Pay on October 18, MacRumors reports
Walgreens (WAG) will begin rolling out Apple Pay (AAPL) on Saturday, October 18, according to a memo obtained by MacRumors. Reference Link
06:13 EDTWAGWalgreen implied volatility of 25 at lower end of index mean range
Subscribe for More Information
05:35 EDTVRTXVertex upgraded to Overweight from Neutral at Piper Jaffray
Piper Jaffray upgraded Vertex Pharmaceuticals to Overweight citing likely approval of the company's Kalydeco plus lumacaftor combination next year. Piper expects Vertex's Cystic Fibrosis sales to grow to $3.1B in 2016 and raised its price target for shares to $125 from $87.50.
October 12, 2014
16:04 EDTCPCSX approached by Canadian Pacific on possible merger, WSJ says
Subscribe for More Information
October 10, 2014
08:24 EDTVRTXVertex price target raised to $117 from $109 at Maxim
Maxim raised its price target for Vertex shares to $117 after the company gave an update at the Cystic Fibrosis Conference. The form keeps a Buy rating on the stock.
06:04 EDTWAGWalgreen implied volatility of 24 at lower end of index mean range
Subscribe for More Information
October 9, 2014
09:33 EDTVRTXVertex says VX-661 Phase 2 study fully enrolled
Subscribe for More Information
07:22 EDTVRTXCystic Fibrosis Foundation to hold a conference
Subscribe for More Information
October 8, 2014
06:02 EDTWAGWalgreen implied volatility of 23 at lower end of index mean range
Subscribe for More Information
October 7, 2014
07:46 EDTVRTXPTC Therapeutics weakness a buying opportunity, says Oppenheimer
Oppenheimer believes that the Street is underestimating the opportunity for PTC Therapeutics' (PTCT) Translarna in the most severe patients with Cystic fibrosis. The firm thinks the drug is not competitive with, and can potentially be complemented by, therapies from Vertex (VRTX). Oppenheimer views the weakness in PTC as a buying opportunity and keeps its Outperform rating on the shares.
October 6, 2014
11:00 EDTWAGOptions with decreasing implied volatilit
Subscribe for More Information
07:16 EDTCPCanadian Pacific price target raised to $265 from $229 at Credit Suisse
Credit Suisse raised Canadian Pacific's price target to $265 and increased estimates following the favorable update in long-term targets. Shares are Outperform rated.
1 | 2 | all recent news | >>

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use